Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

A case of treating cathinone dependence and comorbid depression using bupropion.

Lev-Ran S.

J Psychoactive Drugs. 2012 Nov-Dec;44(5):434-6.

PMID:
23457895
2.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
3.
4.

Treating common psychiatric disorders associated with attention-deficit/hyperactivity disorder.

Kunwar A, Dewan M, Faraone SV.

Expert Opin Pharmacother. 2007 Apr;8(5):555-62. Review.

PMID:
17376012
5.

[Pharmacotherapy of adult Attention Deficit/Hyperactivity Disorder (ADHD): a systematic review].

Mészáros A, Czobor P, Bálint S, Simon V, Bitter I.

Psychiatr Hung. 2007;22(4):259-70. Hungarian.

PMID:
18167421
6.

[Successful treatment of depression in a Parkinson disease patient with bupropion].

Leentjens AF, Verhey FR, Vreeling FW.

Ned Tijdschr Geneeskd. 2000 Nov 4;144(45):2157-9. Dutch.

PMID:
11086491
7.

An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder.

Wilens TE, Prince JB, Spencer T, Van Patten SL, Doyle R, Girard K, Hammerness P, Goldman S, Brown S, Biederman J.

Biol Psychiatry. 2003 Jul 1;54(1):9-16.

PMID:
12842303
8.

The efficacy and tolerability of bupropion in the treatment of major depressive disorder.

Moreira R.

Clin Drug Investig. 2011 Oct 19;31 Suppl 1:5-17. doi: 10.2165/1159616-S0-000000000-00000. Review.

PMID:
22015858
9.

Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults.

Castaneda R, Levy R, Hardy M, Trujillo M.

Psychiatr Serv. 2000 Feb;51(2):169-71. No abstract available.

PMID:
10654994
10.

Efficacy of bupropion in the treatment of pemoline dependence.

Martín Morgado B, Vaz Leal FJ, Bolívar Perálvarez M, Guisado Macías JA.

Actas Esp Psiquiatr. 2007 Jul-Aug;35(4):277-8.

PMID:
17592792
11.

Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.

Levin FR, Evans SM, Brooks DJ, Kalbag AS, Garawi F, Nunes EV.

Drug Alcohol Depend. 2006 Feb 1;81(2):137-48. Epub 2005 Aug 15.

PMID:
16102908
12.

[Beta-cathinone derivatives--a new generation of dangerous psychostimulant "designer drugs"].

Zawilska JB, Słomiak K, Wasiak M, Woźniak P, Massalski M, Krupa E, Wojcieszak JŁ.

Przegl Lek. 2013;70(6):386-91. Polish.

PMID:
24052975
13.

Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder.

Lee MS, Yang JW, Ko YH, Han C, Kim SH, Lee MS, Joe SH, Jung IK.

Child Psychiatry Hum Dev. 2008 Jun;39(2):201-9. Epub 2007 Aug 31.

PMID:
17763937
14.

Treatment of comorbid attention deficit hyperactivity disorder and depression in pediatric patient.

Moura MA.

Rev Bras Psiquiatr. 2007 Jun;29(2):189-90. No abstract available.

15.

Bupropion as the treatment of choice in depression associated with Parkinson's disease and it's various treatments.

Raskin S, Durst R.

Med Hypotheses. 2010 Dec;75(6):544-6. doi: 10.1016/j.mehy.2010.07.024. Epub 2010 Aug 12.

PMID:
20708340
16.

An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder.

Riggs PD, Leon SL, Mikulich SK, Pottle LC.

J Am Acad Child Adolesc Psychiatry. 1998 Dec;37(12):1271-8.

PMID:
9847499
17.

Extended-release bupropion: an antidepressant with a broad spectrum of therapeutic activity?

Clayton AH.

Expert Opin Pharmacother. 2007 Mar;8(4):457-66. Review.

PMID:
17309340
18.

Impact of ADHD and its treatment on substance abuse in adults.

Wilens TE.

J Clin Psychiatry. 2004;65 Suppl 3:38-45. Review.

19.

Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults.

Kuperman S, Perry PJ, Gaffney GR, Lund BC, Bever-Stille KA, Arndt S, Holman TL, Moser DJ, Paulsen JS.

Ann Clin Psychiatry. 2001 Sep;13(3):129-34.

PMID:
11791949
20.

Mechanism of action of agents used in attention-deficit/hyperactivity disorder.

Wilens TE.

J Clin Psychiatry. 2006;67 Suppl 8:32-8. Review.

Supplemental Content

Support Center